Contact
Please use this form to send email to PR contact of this press release:
ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
TO:
Please use this form to send email to PR contact of this press release:
ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
TO: